<VariationArchive VariationID="14547" VariationName="NM_000228.3(LAMB3):c.1439_1443del (p.Pro480fs)" VariationType="Deletion" Accession="VCV000014547" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-10" DateCreated="2015-04-20" MostRecentSubmission="2022-05-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29586" VariationID="14547">
      <GeneList>
        <Gene Symbol="LAMB3" FullName="laminin subunit beta 3" GeneID="3914" HGNC_ID="HGNC:6490" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q32.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209614870" stop="209652425" display_start="209614870" display_stop="209652425" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209788214" stop="209825819" display_start="209788214" display_stop="209825819" Strand="-" />
          </Location>
          <OMIM>150310</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000228.3(LAMB3):c.1439_1443del (p.Pro480fs)</Name>
      <CanonicalSPDI>NC_000001.11:209627424:ACACG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q32.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209627425" stop="209627429" display_start="209627425" display_stop="209627429" variantLength="5" positionVCF="209627424" referenceAlleleVCF="CACACG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209800770" stop="209800774" display_start="209800770" display_stop="209800774" variantLength="5" positionVCF="209800769" referenceAlleleVCF="CACACG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P480fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.209800770_209800774del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.209800770_209800774del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.209627425_209627429del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.209627425_209627429del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007116.1" sequenceAccession="NG_007116" sequenceVersion="1" change="g.30047_30051del">
            <Expression>NG_007116.1:g.30047_30051del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000228.3" sequenceAccession="NM_000228" sequenceVersion="3" change="c.1439_1443del" MANESelect="true">
            <Expression>NM_000228.3:c.1439_1443del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000219.2" sequenceAccession="NP_000219" sequenceVersion="2" change="p.Pro480fs">
            <Expression>NP_000219.2:p.Pro480fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001017402.2" sequenceAccession="NM_001017402" sequenceVersion="2" change="c.1439_1443del">
            <Expression>NM_001017402.2:c.1439_1443del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001017402.1" sequenceAccession="NP_001017402" sequenceVersion="1" change="p.Pro480fs">
            <Expression>NP_001017402.1:p.Pro480fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127641.1" sequenceAccession="NM_001127641" sequenceVersion="1" change="c.1439_1443del">
            <Expression>NM_001127641.1:c.1439_1443del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121113.1" sequenceAccession="NP_001121113" sequenceVersion="1" change="p.Pro480fs">
            <Expression>NP_001121113.1:p.Pro480fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000228.2" sequenceAccession="NM_000228" sequenceVersion="2" change="c.1439_1443delCGTGT">
            <Expression>NM_000228.2:c.1439_1443delCGTGT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA257282" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="150310.0010" DB="OMIM" />
        <XRef Type="rs" ID="786205095" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 9856855 Fig. 1C to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000228.3(LAMB3):c.1439_1443del (p.Pro480fs) AND Junctional epidermolysis bullosa, non-Herlitz type" Accession="RCV000015648" Version="26">
        <ClassifiedConditionList TraitSetID="2422">
          <ClassifiedCondition DB="MedGen" ID="C0268374">Junctional epidermolysis bullosa, non-Herlitz type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000228.3(LAMB3):c.1439_1443del (p.Pro480fs) AND Junctional epidermolysis bullosa" Accession="RCV002228028" Version="1">
        <ClassifiedConditionList TraitSetID="13197">
          <ClassifiedCondition DB="MedGen" ID="C0079301">Junctional epidermolysis bullosa</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-04-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-04-27" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-04-20" MostRecentSubmission="2022-05-16">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">29900604</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30046887</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9038345</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9856855</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="13197" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9513" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa</ElementValue>
                <XRef ID="MONDO:0017612" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2152" />
                <XRef ID="2152" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="305" DB="Orphanet" />
              <XRef ID="C0079301" DB="MedGen" />
              <XRef ID="MONDO:0017612" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS226650" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2422" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5023" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, PROGRESSIVE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, SEVERE NONLETHAL</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, non-herlitz type, somatic mosaic revertant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adult junctional epidermolysis bullosa</ElementValue>
                <XRef ID="33662006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa, non-Herlitz type</ElementValue>
                <XRef ID="MONDO:0009180" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2151" />
                <XRef ID="2151" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMB3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMC2-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMA3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="251393" DB="Orphanet" />
              <XRef ID="79402" DB="Orphanet" />
              <XRef ID="79405" DB="Orphanet" />
              <XRef ID="89840" DB="Orphanet" />
              <XRef ID="C0268374" DB="MedGen" />
              <XRef ID="MONDO:0009180" DB="MONDO" />
              <XRef Type="MIM" ID="226650" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="35913" SubmissionDate="2015-04-17" DateLastUpdated="2015-04-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="150310.0010_EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE" title="LAMB3, 5-BP DEL, NT1438_EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE" />
        <ClinVarAccession Accession="SCV000035913" DateUpdated="2015-04-20" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 27-year-old woman with nonlethal junctional epidermolysis bullosa (EB) (226650) and her identically affected younger brother, Pulkkinen and Uitto (1998) found a 5-bp deletion (1438del5) in the LAMB3 gene that resulted in a premature termination codon 164 nucleotides downstream from the deletion within exon 14. The mutation was present in compound heterozygous state with the frequent R635X (150310.0001) mutation. Pulkkinen and Uitto (1998) could provide no ready explanation for the discrepancy between genotype and expected phenotype in this case. Mosaicism as a result of gene conversion, as demonstrated previously in nonlethal junctional EB due to mutation in the COL17A1 gene (113811) by Jonkman et al. (1997), was unlikely because the affected brother had a similar phenotypic presentation.</Attribute>
              <Citation>
                <ID Source="PubMed">9856855</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">9038345</ID>
              </Citation>
              <XRef DB="OMIM" ID="226650" Type="MIM" />
              <XRef DB="OMIM" ID="113811" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <Name>LAMB3, 5-BP DEL, NT1438</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">5-BP DEL, NT1438</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="150310.0010" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4908035" SubmissionDate="2022-05-12" DateLastUpdated="2022-05-16" DateCreated="2022-05-16">
        <ClinVarSubmissionID localKey="NM_000228.2:c.1439_1443delCGTGT|MedGen:C0079301" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002511431" DateUpdated="2022-05-16" DateCreated="2022-05-16" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29900604</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30046887</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9856855</ID>
          </Citation>
          <Comment>Variant summary: LAMB3 c.1439_1443delCGTGT (p.Pro480ArgfsX54) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 250770 control chromosomes (gnomAD). c.1439_1443delCGTGT has been reported in the literature in at least two compound heterozygous individuals (siblings) affected with Junctional Epidermolysis Bullosa in one family (Pulkkinen_1998). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000228.2:c.1439_1443delCGTGT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0079301" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11463985</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4908035" TraitType="Disease" MappingType="XRef" MappingValue="C0079301" MappingRef="MedGen">
        <MedGen CUI="C0079301" Name="Junctional epidermolysis bullosa" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="35913" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE" MappingRef="Preferred">
        <MedGen CUI="C0268374" Name="Junctional epidermolysis bullosa, non-Herlitz type" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

